Waseem brings 20 years of global, regional and local hands-on experience across the pharmaceutical, medical device and healthcare sector across clinical development, product strategy development and commercialization including pricing & reimbursement, market access, HEOR and government / public affairs. Waseem’s professional experience spans across telecommunications (British Telecom), Retail (Next Plc, Sainsbury’s), Information Technology (Micro Direct, Digipharm) Management Consulting for consultancy companies such as Parexel, Purple Squirrel Economics, Alira Health, Ascenian, Decision Resources Group /

Clarivate, CHEORS and pharmaceutical companies including ,but not limited, to Ferring Pharmaceuticals, Amryt Pharma, GSK, Aspen, Bayer, ResMed, iRhythym, Glaukos, Merck, MSD.

• Owner and Co-Founder of boutique market access consultancy with a turnover in excess of £500,000

• Lead pricing consultant on project with the European Commission spanning across 33 countries involving simultaneous price reduction applications, rebate calculation and methodology proposal to member states, price waterfall development

• Co-author of 5 peer reviewed scientific publications

• Identification and mapping of fertility treatment policies in Europe across 43 countries to help shape policy and guidelines in IVF

• Collaboration on multiple early advice requests, adaptive pathway preparations and multiple submissions to national health technology assessments on a global level

• Successful delivery of projects across both pharmaceuticals and medical device sector from early development to post launch

• Global Project experience including Europe, US, APAC, LATAM and Emerging Markets

Broad therapy area exposure including but not limited to Cardiovascular, Allergy, Dermatology, HIV, Hepatitis, Substance Misuse, Urology, Women’s Health, MSK, Mental Health – Depression, Schizophrenia, Bipolar, Asthma, Osteoarthritis, Neuroscience, Multiple Sclerosis, Diabetes, Oncology, Respiratory (COPD/Sleep Apnoea), IVF. Digital Health & Apps, Disruptive Technologies, Oncology (Endometrial Cancer, Cervical Cancer, Melanoma).

Specialties: Health Technology Assessment, Epidemiology, Pricing & Reimbursement, Market Access, Life Cycle Management, Medical Writing including Value Dossiers (GVD; AMCP), Manuscripts, Abstracts (Member of European Medical Writing Association), Systematic Literature Reviews, Value Proposition + Value message development, Marketing Strategy Development (Member of Chartered Institute of Marketing), Political Lobbying, Business Development, Landscape Assessment, Healthcare Strategy.

Chemical Sciences Degree from Manchester Metropolitan University, PGCert in International HTA, Pricing and Reimbursement, PGCert; PGDip in International HTA from University of Glasgow, PGCert in Business Administration alongside courses in Senior Management; Strategy from the Open University, Market Access Diploma (EMAUD) complemented with a Master of Business Administration from Herriot Watt University.

Additional courses studied at BHBIA, INSEAD, YHEC, Harvard Business School, King’s College London, University of Copenhagen, Macquarie School of Management, University of East Anglia.

Waseem is based in Europe and when he is not working or studying, he actively fundraises for a charity called Street Children Pakistan where is a Non-Executive Director. Waseem has a passion for healthcare in LMIC and wants to use his voice to speak for those in need of access to healthcare by removing barriers across healthcare systems. In his spare time Waseem likes to spend as much time with his two boys Raheem (eight) and Habib (two) and wife Nazia on planning adventures and trips to far flung destinations.